Top Story

Patient-reported symptoms linked to disease activity changes in SSc

September 10, 2019
FDA News

FDA approves nintedanib for systemic sclerosis-associated ILD

September 6, 2019
The FDA has approved nintedanib capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or…
Meeting News

In scleroderma, rheumatology nurses essential to treat the ‘whole patient’

August 12, 2019
ORLANDO — Rheumatology nurses are necessary for helping to care for “the whole patient” with scleroderma, including its various manifestations and…
FDA News

FDA panel supports approval of nintedanib for systemic sclerosis-associated ILD

July 26, 2019
The FDA Arthritis Advisory Committee voted 10-7 to recommend approval of nintedanib for treatment of systemic sclerosis-associated interstitial lung disease. The…
More Headlines »

Early Diagnosis & Optimal Care of Ankylosing Spondylitis

This activity is supported by an independent educational grant from AbbVie.

Ankylosing spondylitis (AS), the most common spondyloarthropathy, is a chronic, progressive, debilitating inflammatory…
More »
Meeting News

VIDEO: Anabasum shows acceptable safety, tolerability for diffuse system sclerosis

November 6, 2017
More »

Ace the Case: A 76-Year-Old Female With White Discoloration of Fingers

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 76-year-old female with the…
More »